Nitrofurantoin Safety and Efficacy in Pediatric Patients

Age-Specific Safety Guidelines

• The European Urology guidelines recommend avoiding nitrofurantoin in infants <1 month of age due to risk of hemolytic anemia, and using with caution in infants <4 months 1, 2
• The Journal of Microbiology, Immunology and Infection states that nitrofurantoin is absolutely contraindicated in infants <1 month of age 3
• The Taiwan FDA does not approve nitrofurantoin for children <12 years, though it is widely used off-label with established safety data 3

Pediatric Dosing

• The Journal of Microbiology, Immunology and Infection recommends a treatment dose of 5-7 mg/kg/day PO divided into 4 doses, with a maximum single dose of 100 mg 3
• The European Urology guidelines suggest a prophylaxis dose of quarter to half of the therapeutic dose 1, 2
• The JAMA network open recommends a treatment duration of 5 days for uncomplicated cystitis 4
• The Journal of Microbiology, Immunology and Infection recommends a treatment duration of at least 7 days, or 3 days after sterile urine 3

Clinical Indications in Pediatrics

• The JAMA network open, Clinical Microbiology and Infection, and other guidelines recommend nitrofurantoin as first-line for uncomplicated cystitis in children >1 month 4, 5, 6
• The European Urology guidelines recommend nitrofurantoin for prophylaxis of vesicoureteral reflux (VUR) and recurrent UTI 1, 2

Guideline Recommendations

• The WHO Essential Medicines recommends nitrofurantoin as first-choice for lower UTI 5, 6
• The IDSA/ESMID recommends nitrofurantoin as first-line for uncomplicated cystitis 5, 6
• The European Urology Guidelines commonly use nitrofurantoin for continuous antibiotic prophylaxis 1, 2

Key Clinical Pitfalls to Avoid

• The European Urology guidelines warn against violating age restrictions, and exercising caution in infants <4 months 1, 2
• The Journal of Microbiology, Immunology and Infection advises against using nitrofurantoin for pyelonephritis or systemic infections 3